| Summary: | Objective: Oxaliplatin/ 5- Fluorouracil/ Leucovorin is an effective therapy for patients with metastatic colorectal cancer. The aim of this study was to explore the efficacy and safety of this chemotherapy regimen in the treatment of patient with advanced colorectal cancer.
Methods: From January 2008 to May 2010 twenty six consecutive patients with advanced colorectal cancer entered the study. Treatment schedule consist of intravenous Oxaliplatin 80 mg/m2 on day 1, Leucovorin 200 mg/m2 administered as intravenous infusion on day 1 and 2 and 5- Fluorouracil 400 mg/m2 bolus followed by 5- Fluorouracil 600 mg/m2 as 22- hours infusion with repetition every two weeks.
Results: Overall response rate was 34,6% with one complete response and eight partial responses achieved. The overall survival time was 12,6 months. The main toxicity observed were leukopenia and diarrhea.
Conclusions: That data suggest that chemotherapy with Oxaliplatin/ 5- Fluorouracil/ Leucovorin remain reasonable chemotherapy regimen for the treatment of patients with advanced or metastatic colorectal cancer.
|
|---|
